To the Editor:

Recent cohort studies frequently reported low rate of fever in coronavirus disease 2019 (COVID-19) patients \[[@CR1], [@CR2]\], which was in sharp contrast with previous studies that reported \> 98% of patients presented fever on admission \[[@CR3], [@CR4]\]. Fever is a protective response for infections and an important criterion in the diagnosis of COVID-19. To understand the prevalence of fever in COVID-19 and its correlation with other symptoms and outcomes, we conducted a chart review of 252 hospitalized patients from 15 participating hospitals in Guangdong, Hubei, and Jiangxi provinces, China, from January 19 to March 6, 2020 (Table [1](#Tab1){ref-type="table"}). Diagnosis of COVID-19 was based on positive severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) reverse transcription-PCR test. Our study was approved by the institutional review boards of the Sun Yat-sen University and the participating hospitals. Table 1Demographics and clinical characteristics of COVID-19 patients on admissionTotal (*n* = 252)Febrile (*n* = 197)Non-febrile (*n* = 55)*P* valueAge, years ≤ 2926 (10%)16 (8%)10 (18%)0.121 30--49106 (42%)85 (43%)21 (38%) 50--6994 (37%)73 (37%)21 (38%) ≥ 7026 (10%)23 (12%)3 (5%)Sex Female110 (44%)82 (42%)28 (51%)0.231 Male141 (56%)114 (58%)27 (49%)Temperature, °C \< 37.355 (22%)055 (100%)**\< 0.001** 37.3--38.0104 (41%)104 (53%)0 38.1--3980 (32%)80 (41%)0 39.1--4113 (5%)13 (7%)0Signs and symptoms Cough177 (70%)145 (74%)32 (58%)**0.027** Myalgia42 (17%)33 (17%)9 (16%)0.946 Cephalalgia22 (9%)12 (6%)10 (18%)**0.005** Sputum105 (42%)92 (47%)13 (24%)**0.002** Hemoptysis4 (2%)4 (2%)00.579 Diarrhea28 (11%)23 (12%)5 (9%)0.590 Dyspnea35 (14%)28 (14%)7 (13%)0.768 Poor appetite140 (56%)117 (59%)23 (42%)**0.020**Comorbidity Hypertension48 (19%)39 (20%)9 (16%)0.566 Diabetes18 (7%)14 (7%)4 (7%)1.000 Digestive tract disease4 (2%)2 (1%)2 (4%)0.444 Cardiovascular disease10 (4%)8 (4%)2 (4%)1.000 Cerebrovascular disease3 (1%)3 (2%)01.000 Malignancy4 (2%)2 (1%)2 (4%)0.444 Liver disease6 (2%)3 (2%)3 (5%)0.234 Chronic lung disease8 (3%)5 (3%)3 (5%)0.512Treatments and outcomes Oxygen supplementation200 (79%)157 (80%)43 (78%)0.806 Mechanical ventilation10 (4%)9 (5%)1 (2%)0.594 ECMO4 (2%)4 (2%)00.579 Critically ill52 (21%)40 (20%)12 (22%)0.806 ARDS21 (8%)17 (9%)4 (7%)0.963 ICU admission43 (17%)34 (17%)9 (16%)0.876 Mortality6 (2%)6 (3%)00.344Data are median (IQR) or *n* (%). *P* values comparing febrile and non-febrile are from Mann-Whitney U test, *χ*^2^ test, or Fisher's exact test, as appropriateMedical records of COVID-19 patients were accessed from Jingzhou Hospital of Traditional Chinese Medicine (61 cases), Jianli Hospital of Traditional Chinese Medicine (41 cases), Jingzhou Central Hospital (21 cases), Dongguan People's Hospital (14 cases), Jieyang People's Hospital (8 cases), Shangrao People's Hospital (12 cases), Shangrao No.2 People's Hospital (3 cases), Poyang People's Hospital (53 cases), Yugan People's Hospital (3 cases), Wuyuan People's Hospital (5 cases), Dexing People's Hospital (3 cases), Guangfeng People's Hospital (16 cases), Yushan People's Hospital (9 cases), Yanshan People's Hospital (2 cases), and Wannian People's Hospital (1 case)*ECMO* extracorporeal membrane oxygenation, *ARDS* acute respiratory distress syndrome, *ICU* intensive care unit

Demographic, clinical, laboratory, treatment, and outcome data were collected. The hospital course was reviewed for severity of disease. Critically ill patients were defined as those admitted to the ICU requiring mechanical ventilation or had a fraction of inspired oxygen (FiO~2~) of at least 60% \[[@CR5]\]. SPSS (Statistical Package for the Social Sciences) version 24.0 software (SPSS Inc.) was used for Mann-Whitney *U*, chi-square, and the Fisher's exact test. All statistical tests were two sided, with *p* values of \< 0.05 considered to be statistically significant.

We found that, on admission, 197 (78%) patients had temperatures ≥ 37.3 °C, 93 (37%) patients had temperatures \> 38 °C, and 13 (5%) patients had temperatures \> 39 °C (Table [1](#Tab1){ref-type="table"}). We then examined the differential symptoms and outcomes between febrile (≥ 37.3 °C) and non-febrile (\< 37.3 °C) patients.

The most common symptoms on admission in both febrile and non-febrile patients were cough, poor appetite, and sputum production (Table [1](#Tab1){ref-type="table"}). Smaller proportion of the non-febrile patients presented cough, poor appetite, and sputum production, compared to the febrile patients. In contrast, larger proportion of the non-febrile patients presented cephalalgia. The negative correlation between cephalalgia and fever is intriguing. Currently, there is no evidence for SARS-CoV-2 infection in brain tissue, although ACE2 expression in neuron was observed. Perhaps inflammatory cytokines from peripheral blood caused headache \[[@CR6]\] in COVID-19. Cephalalgia may be a useful sign for the identification of non-febrile COVID-19, when epidemiological evidence for the infection exists.

No significant difference in any of the recorded comorbidities was observed between febrile and non-febrile patients.

Similar high proportions of febrile (157 \[80%\]) and non-febrile patients (43 \[78%\]) required oxygen supplementation (Table [1](#Tab1){ref-type="table"}), indicating that respiratory system was the most affected system for both groups of patients. Among these, 17 (9%) febrile and 4 (7%) non-febrile patients developed acute respiratory distress syndrome (ARDS). Forty-three (17%) febrile and 9 (16%) non-febrile patients were admitted to the ICU. Critical illness was similarly common in the febrile (40 patients \[20%\]) and non-febrile (12 patients \[22%\]) patients.

Fever promotes inflammatory reaction, which may help control viral infection leading to beneficial outcomes. However, fever-induced upregulation of the inflammatory cytokines such as IL-1, TNF, and IL-6 may contribute to cytokine storm that contributes to critical illness. These double-edged effects of fever may explain the absence of correlation between fever and the disease outcome.

Given the high proportion of non-febrile patients in COVID-19, and that 20% non-febrile patients became critically ill, heightened attention for this elusive group of patients may be required for a better containment of the pandemic. Our finding is a timely alarm for health care workers and general population that temperature monitoring alone does not identify many of the COVID-19 patients.
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